246 related articles for article (PubMed ID: 27430248)
21. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF
Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376
[TBL] [Abstract][Full Text] [Related]
22. An enzymatically fortified ginseng extract inhibits proliferation and induces apoptosis of KATO3 human gastric cancer cells via modulation of Bax, mTOR, PKB and IκBα.
Hwang JW; Baek YM; Jang IS; Yang KE; Lee DG; Yoon SJ; Rho J; Cho CK; Lee YW; Kwon KR; Yoo HS; Sung JS; Kim S; Park JW; Jang BC; Choi JS
Mol Med Rep; 2015 Jan; 11(1):670-6. PubMed ID: 25333578
[TBL] [Abstract][Full Text] [Related]
23. Ginsenoside Rg3 attenuates ovariectomy-induced osteoporosis via AMPK/mTOR signaling pathway.
Zhang X; Huang F; Chen X; Wu X; Zhu J
Drug Dev Res; 2020 Nov; 81(7):875-884. PubMed ID: 32898934
[TBL] [Abstract][Full Text] [Related]
24. 20(S)-Ginsenoside Rg3 prevents endothelial cell apoptosis via inhibition of a mitochondrial caspase pathway.
Min JK; Kim JH; Cho YL; Maeng YS; Lee SJ; Pyun BJ; Kim YM; Park JH; Kwon YG
Biochem Biophys Res Commun; 2006 Oct; 349(3):987-94. PubMed ID: 16962070
[TBL] [Abstract][Full Text] [Related]
25. Synergistic antitumor effect of ginsenoside Rg3 and cisplatin in cisplatin‑resistant bladder tumor cell line.
Lee YJ; Lee S; Ho JN; Byun SS; Hong SK; Lee SE; Lee E
Oncol Rep; 2014 Nov; 32(5):1803-8. PubMed ID: 25175462
[TBL] [Abstract][Full Text] [Related]
26. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
27. Ginsenoside Rg3 Reduces Epithelial-Mesenchymal Transition Induced by Transforming Growth Factor-β1 by Inactivation of AKT in HMrSV5 Peritoneal Mesothelial Cells.
Yan X; Zhang W; Kong F; Li Q; Shan W; Zhang C; Han T; Che Y; Zhang Y
Med Sci Monit; 2019 Sep; 25():6972-6979. PubMed ID: 31527568
[TBL] [Abstract][Full Text] [Related]
28. Ginsenoside Rg3 attenuates myocardial ischemia/reperfusion injury via Akt/endothelial nitric oxide synthase signaling and the B‑cell lymphoma/B‑cell lymphoma‑associated X protein pathway.
Wang Y; Hu Z; Sun B; Xu J; Jiang J; Luo M
Mol Med Rep; 2015 Jun; 11(6):4518-24. PubMed ID: 25672441
[TBL] [Abstract][Full Text] [Related]
29. Icariin enhances the chemosensitivity of cisplatin‑resistant ovarian cancer cells by suppressing autophagy via activation of the AKT/mTOR/ATG5 pathway.
Jiang S; Chang H; Deng S; Fan D
Int J Oncol; 2019 Jun; 54(6):1933-1942. PubMed ID: 31081049
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of mitotic Aurora kinase A by alisertib induces apoptosis and autophagy of human gastric cancer AGS and NCI-N78 cells.
Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Wang NJ; Zhao RJ; Zhou SF
Drug Des Devel Ther; 2015; 9():487-508. PubMed ID: 25609923
[TBL] [Abstract][Full Text] [Related]
31. 20(S)-ginsenoside Rg3 promotes senescence and apoptosis in gallbladder cancer cells via the p53 pathway.
Zhang F; Li M; Wu X; Hu Y; Cao Y; Wang X; Xiang S; Li H; Jiang L; Tan Z; Lu W; Weng H; Shu Y; Gong W; Wang X; Zhang Y; Shi W; Dong P; Gu J; Liu Y
Drug Des Devel Ther; 2015; 9():3969-87. PubMed ID: 26309394
[TBL] [Abstract][Full Text] [Related]
32. Ginsenoside Rh2 and Rg3 inhibit cell proliferation and induce apoptosis by increasing mitochondrial reactive oxygen species in human leukemia Jurkat cells.
Xia T; Wang YN; Zhou CX; Wu LM; Liu Y; Zeng QH; Zhang XL; Yao JH; Wang M; Fang JP
Mol Med Rep; 2017 Jun; 15(6):3591-3598. PubMed ID: 28440403
[TBL] [Abstract][Full Text] [Related]
33. Dihydroartemisinin and gefitinib synergistically inhibit NSCLC cell growth and promote apoptosis via the Akt/mTOR/STAT3 pathway.
Jin H; Jiang AY; Wang H; Cao Y; Wu Y; Jiang XF
Mol Med Rep; 2017 Sep; 16(3):3475-3481. PubMed ID: 28713965
[TBL] [Abstract][Full Text] [Related]
34. Ginsenoside Rg3 induces apoptosis in the U87MG human glioblastoma cell line through the MEK signaling pathway and reactive oxygen species.
Choi YJ; Lee HJ; Kang DW; Han IH; Choi BK; Cho WH
Oncol Rep; 2013 Sep; 30(3):1362-70. PubMed ID: 23783960
[TBL] [Abstract][Full Text] [Related]
35. Ginsenoside Rg3 enhances the anticancer effect of 5‑FU in colon cancer cells via the PI3K/AKT pathway.
Hong S; Cai W; Huang Z; Wang Y; Mi X; Huang Y; Lin Z; Chen X
Oncol Rep; 2020 Oct; 44(4):1333-1342. PubMed ID: 32945504
[TBL] [Abstract][Full Text] [Related]
36. Ginsenoside Rg3 enhances the radiosensitivity of lung cancer A549 and H1299 cells via the PI3K/AKT signaling pathway.
Li J; Yang B
In Vitro Cell Dev Biol Anim; 2023 Jan; 59(1):19-30. PubMed ID: 36790693
[TBL] [Abstract][Full Text] [Related]
37. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
[TBL] [Abstract][Full Text] [Related]
38. Ginsenosides Inhibit the Proliferation of Lung Cancer Cells and Suppress the Rate of Metastasis by Modulating EGFR/VEGF Signaling Pathways.
Yu X; Wang Q; Dai Z
J Oleo Sci; 2024; 73(2):219-230. PubMed ID: 38311411
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous targeting of PI3K and mTOR with NVP-BGT226 is highly effective in multiple myeloma.
Baumann P; Schneider L; Mandl-Weber S; Oduncu F; Schmidmaier R
Anticancer Drugs; 2012 Jan; 23(1):131-8. PubMed ID: 21959532
[TBL] [Abstract][Full Text] [Related]
40. Effects of ginsenoside Rg3 on epigenetic modification in ovarian cancer cells.
Zhao L; Shou H; Chen L; Gao W; Fang C; Zhang P
Oncol Rep; 2019 Jun; 41(6):3209-3218. PubMed ID: 31002353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
